Fund Tracker
SUVENNSEHealthcareHealthcare Services

Suven Life Sciences Limited

₹335.00NSE close, 25 Sep 2026
Data as of10 sources, each card shows its own date
MF: Aug 2026 portfolios (monthly), 20 AMCsShares outstanding and close: NSE, 25 Sep 2026Delivery: NSE bhavcopy, 25 Sep 2026 · 30 days collectedDeals: NSE deal files, 25 Sep 2026 · collected since 25 Sep 2026SLBM: NSE, 25 Sep 2026 · 30 days collectedMTF: NSE, 24 Sep 2026 · 29 days collectedFlags: NSE, 25 Sep 2026FPI: Shareholding pattern as of 8 Jul 2026, filed 20 Jul 2026Pledge: Shareholding pattern as of 8 Jul 2026Insider: Disclosures filed 29 Jun 2026 to 26 Sep 2026 (collected since 3 May 2026)
MF holding, % of equity
0.00%▼ −0.00 pp
Aug 2026 · change vs Jul 2026 over 20 AMCs with both months, all schemes
FPI holding, % of equity
0.48%▼ −0.08 pp
as of 8 Jul 2026
Fund houses holding
0no change
0 entered, 0 exited · Aug 2026 · index funds hidden
Promoter pledge
0.00%■ 0.00 pp
as of 8 Jul 2026

What changed

No tracked fund house held SUVEN in Aug 2026 (20 AMCs tracked).

MF houses

Aug 2026
0no change m/m

No tracked fund house held SUVEN in Aug 2026.

AMC portfolios, Aug 2026 · 20 AMCs trackedSource: AMC monthly portfolios (SEBI disclosure) 0 fund houses →

Named FPIs at 1% or more

as of 8 Jul 2026
0.48%▼ −0.08 pp vs 30 Jun 2026

FPI category I + II, % of total shares · 0 named at 1% or more

No FPI held 1% or more of SUVEN on 8 Jul 2026.

Shareholding pattern as of 8 Jul 2026, filed 20 Jul 2026Source: NSE shareholding pattern filings (XBRL), quarterly

Insider and promoter

29 Jun 2026 to 26 Sep 2026
No insider or promoter trade in SUVEN was disclosed 29 Jun 2026 to 26 Sep 2026.
Disclosures filed 29 Jun 2026 to 26 Sep 2026 (collected since 3 May 2026)Source: NSE insider trading disclosures (SEBI PIT, XBRL)

Bulk and block deals

25 Sep 2026
No bulk or block deals in SUVEN on 25 Sep 2026.
NSE deal files, 25 Sep 2026 · collected since 25 Sep 2026Source: NSE bulk.csv and block.csv, daily

Promoter pledge

as of 8 Jul 2026
0.00%■ 0.00 pp vs 30 Jun 2026

of promoter holding · 0.00% of total shares

Promoters had pledged 0 of their 18.50 cr shares on 8 Jul 2026.

Shareholding pattern as of 8 Jul 2026Source: NSE shareholding pattern filings (XBRL), quarterly

SLBM borrowing

25 Sep 2026
NSE listed no SLBS open position for SUVEN on any of the 30 days collected, 14 Aug 2026 to 25 Sep 2026. No SLBM trades in SUVEN on 25 Sep 2026.
NSE, 25 Sep 2026 · 30 days collectedSource: NSE SLBS open positions (slb_openpos) and SLBM bhavcopy (SLBM_BC), daily

MTF book

24 Sep 2026
22.17 lakh sh▼ −76,991 vs 23 Sep 2026

percentile 62 of 29 days collected · ₹65.9 cr financed

22.17 lakh shares, 0.78% of equity in the margin trading book at the end of 24 Sep 2026; that day sits at percentile 62 of 29 days collected.

NSE, 24 Sep 2026 · 29 days collectedSource: NSE margin trading disclosure (mrg_trading), daily

Delivery

25 Sep 2026
42.1%▼ −2.0 pp vs 20-day average

20-day average 44.1% · percentile 60 of 30 days collected

42.1% of the shares traded on 25 Sep 2026 were delivered, against a 20-day average of 44.1%; that day sits at percentile 60 of 30 days collected.

NSE bhavcopy, 25 Sep 2026 · 30 days collectedSource: NSE security-wise delivery file (sec_bhavdata_full), daily

Red flags

25 Sep 2026
Long-term ASM stage 1

SUVEN has no F&O contracts in NSE's combined open-interest file, so the F&O ban does not apply. On 25 Sep 2026 NSE listed SUVEN under long-term ASM stage 1. Pledge invocations are not collected yet.

NSE, 25 Sep 2026Source: NSE F&O ban file, combined OI (MWPL), surveillance indicators (REG1_IND), daily